Company: RPTX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103764
Chunk: 47

Company: Repare Therapeutics Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 47
---
 that we are required to prepare an accounting restatement due to material noncompliance with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period, then we are required to recoup reasonably promptly any incentive-based compensation that exceeds the amount of compensation that would have been received had such amount been determined based on the accounting restatement. The policy applies to compensation earned during the three completed fiscal years immediately preceding the date it is determined that an accounting restatement is required (excluding fiscal years completed prior to the effective date of the policy), and grants our compensation committee broad flexibility in recouping recoverable incentive compensation. Policies and Practices Related to the Grant of Certain Equity Awards Close in Time to the Release of Material Nonpublic Information From time to time, we grant stock options to our employees, including our named executive officers. Our typical practice is to grant new-hireoption awards on or soon after a new hire’s employment start date and annual refresh employee option grants in the first quarter of each fiscal year, which refresh grants are typically approved at the regularly scheduled meeting of the compensation committee or board of directors, as applicable, occurring in the first quarter of the relevant fiscal year.Also, non-employeedirectors receive automatic grants of initial and annual stock option awards, at the time of a director’s initial appointment or election to the board of directors and at the time of each annual meeting of our shareholders, respectively, pursuant to the non-employeedirector compensation program, as further described under the heading “Non-EmployeeDirector Compensation”. We do not otherwise maintain any written policies on the timing of awards of stock options, stock appreciation rights, or similar instruments with option-like features. The compensation committee considers whether there is any material nonpublic information (“MNPI”) about us when determining the timing of stock option grants but does not seek to time the award of stock options in relation to our public disclosure of MNPI. We have not timedthe release of MNPI for the purpose of affecting the value of executive compensation. 34

**Compensation Risk Assessment

The compensation committee has reviewed our compensation policies and practices, in consultation with the compensation consultant and outside counsel, to assess whether they encourage employees to take inappropriate risks. After conducting this review of compensation-related risk, the compensation committee has concluded that our compensation policies and